4,0
20 dec 2023
Voormalige werknemer
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Great flagship product with a big, untapped market and growing levels of evidence. You can get easily behind the mission and feel connected to the patient impact.
Minpunten
The sales growth (and stock price) has been lower than target, partially due to lack of focus from the leadership.